StockSelector.com
  Research, Select, & Monitor Thursday, April 26, 2018 9:03:34 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Biostar Pharmaceuticals, Inc.$2.10($.03)(1.41%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Biostar Pharmaceuticals, Inc. vs Chemicals - Major Diversified

BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.




Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: N/A $96,060.6 Mil
  Market Cap: $5.6 Mil $230,285.6 Mil
  Analysts Recommendation: N/A Buy

 Averages Company Industry
 Growth
  Historic Revenue: N/A 1.7%
  Estimated Revenue: N/A 16.8%
  Historic Earnings: N/A 4.9%
  Estimated Earnings: N/A 17.2%
  Stock Price (1 Year): 18.1% 11.7%
  Cash per Share: N/A 43.7%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 16.2
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 3.6
  Dividend Yield: N/A N/A
  Market Cap: $5.6 Mil $25,587.3 Mil
  Operations
  Net Margin: N/A 14.4%
  Gross Margin: N/A 37.6%
  Return on Equity: N/A .2
  Return on Assets: N/A .1
  Balance Sheet
  Current Ratio: N/A 1.6
  Quick Ratio: N/A 1.2
  Cash Ratio: N/A .3
  Debt-to-Equity: N/A 1.7
  Interest Coverage: N/A .4
 Technicals
  Relative-Strength Index: N/A N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $25.64 $54,705.9 Mil
  Praxair, Inc.  (PX) $155.99 $42,874.9 Mil
  Air Products & Chemicals, Inc.  (APD) $166.29 $36,087.6 Mil
  Henkel KGaA  (HENKY) $118.00 $30,331.7 Mil
  Akzo Nobel N.V.  (AKZOY) $30.77 $23,215.5 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.